3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Neoplasms
4
Breast Neoplasms
4
Myeloproliferative Disorders
3
Melanoma
3
Skin Neoplasms
2
Lung Neoplasms
2
Thrombosis
1
Pyruvate Kinase Deficiency of Red Cells
1
Precancerous Conditions
1
Pancreatic Cyst
1
Neuroendocrine Tumors
1
Neoplasm, Residual
1
Myelodysplastic-Myeloproliferative Diseases
1
Myelodysplastic Syndromes
1
Myelitis, Transverse
1
Myasthenia Gravis
1
Multiple Sclerosis
1
Metastatic Castration-resistant Prostate Cancer
1
Lymphoma, Non-Hodgkin
1
Lymphoma, Large B-Cell, Diffuse
1
Lymphoma, B-Cell
1
Lymphatic Metastasis
1
Locally Advanced Head and Neck Carcinoma
1
Leukemia, Myeloid, Acute
1
Head and Neck Neoplasms
1
HER2-positive Breast Cancer
1
Esophageal Neoplasms
1
Endometrial Neoplasms
1
Diagnosis of Cancer of Various Organs
1
Diabetes Mellitus, Insulin-Dependent, 12
1
Interventions
Magnetic Resonance Spectroscopy
9
Specimen Handling
8
Cisplatin
5
Cetuximab
5
Platinum
4
1,2-diaminocyclohexaneplatinum II citrate
4
cemiplimab
3
Radiotherapy
3
Immunoglobulin G
3
Disulfides
3
Biopsy
3
(225)Ac-DOTA-c(RGDyK)
3
pembrolizumab
2
Radiotherapy, Intensity-Modulated
2
Radiation
2
Nivolumab
2
Carboplatin
2
Bevacizumab
2
trastuzumab deruxtecan
1
temsirolimus
1
niraparib
1
ipatasertib
1
durvalumab
1
dostarlimab
1
cabozantinib
1
atezolizumab
1
Valproic Acid
1
Ultrasonography
1
Transurethral Resection of Bladder
1
Tramadol
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Mouth Neoplasms
×
Blood Specimen Collection
×
30 days
×
Clear all
No trials found.